Physician profile
Joann E Ruiz
NPI 1992765283
$1,534.73
in general payments reported to CMS, 2019-2025
14 companies · $299 in 2025
The $299 reported for 2025 was more than what 84% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $75.12 · 2021: $149 · 2022: $222 · 2023: $459 · 2024: $226 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $983.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $296.74 | 2022-2024 | |
| Glaxosmithkline, LLC. | $240.82 | 2019-2024 | Pediarix, Bexsero, Rotarix |
| Cranial Technologies, INC | $233.16 | 2019-2025 | Doc Band |
| Seqirus USA INC | $152.53 | 2022-2025 | Flucelvax, Flucelvax Quadrivalent |
| Sanofi Pasteur INC. | $151.00 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $136.64 | 2022-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Phadia US INC. | $120.66 | 2019-2024 | Immunocap |
| Genentech USA, INC. | $56.47 | 2021-2022 | |
| Alk-Abello, INC | $45.41 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $23.22 | 2022 | |
| Neurelis, INC. | $21.68 | 2023 | Valtoco |
| Mission Pharmacal Company | $20.64 | 2019 | |
| Oxford Immunotec USA INC | $18.95 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.81 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joann Ruiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.